Transferring a research protocol between labs involves more than moving a document; the receiving lab must trace every vial to its analytical record. A single label reference can separate a clean audit trail from an unresolved documentation gap. This article explains how to match a vial label reference to the corresponding Certificate of Analysis (CoA) during a lab-to-lab transfer, with practical checks for UK laboratory researchers and materials managers. All materials discussed are research-use-only and are not for human or veterinary use.
Why the vial label reference is the first checkpoint in a transferred protocol
Vial labels from Research Sciences use a reference format combining the SKU code and expiry date, for example BPC10-03/27. That reference bridges the physical vial and the CoA that accompanies the batch. When a protocol is transferred, the receiving lab should treat the label reference as the first checkpoint, not an afterthought. The label is not just an inventory tag; it confirms that the analytical documentation in the handover pack belongs to the same material.
Record the full label reference exactly as printed. Do not rely on memory, a handwritten transfer note, or an email subject line. If the label reads BPC10-03/27, capture that entire string in the receiving lab’s materials register. The SKU element identifies the catalogue item; the expiry element distinguishes one batch record from another. Copy the reference character for character. A missing digit or transposed month can send the receiving lab to the wrong CoA and weaken the transfer record.
Vial cap colour and other packaging details should not be used as identity checks. Research Sciences states that cap colours and packaging may vary and are not indicators of identity, analytical quality or manufacturing origin. The label reference, the CoA and the associated Internal Test Reference (ITR) form the documentation trail. An ITR links to associated sample testing reports; it does not by itself confirm that separate deliveries come from the same production lot or have had separate independent testing. That distinction matters when one lab sends part of a batch to another and the receiving lab later orders a restock.
Before the protocol moves, list every vial by label reference and note whether the CoA is in the handover pack. The CoA should be the batch-specific document, not a generic product page or a certificate from a different product. Open the CoA and check that the product name, batch or lot information, and label reference align. Homepage wording for Research Sciences lists “CoAs Janoshik Analytical Reports”; researchers should treat that as the shop’s published statement and verify the actual batch document that accompanies the specific vial. All materials are research-use-only and are not for human or veterinary use.
Creating a CoA cross-reference sheet for the receiving laboratory
A cross-reference sheet is a simple but effective transfer tool. It should list the vial label reference, product name, quantity received, expiry date from the label, CoA file name or identifier, ITR if present, storage condition, and the person who performed the check. For each vial, match the label reference to the CoA before the material is placed in storage or used in an in-vitro workflow.
The first pass is a one-to-one check: label reference on the vial versus the identifier on the CoA. If the CoA does not show the exact label reference, look for the batch or lot number and the ITR. Do not assume a CoA is correct simply because it arrived in the same box. Documentation can be misfiled, especially when a protocol transfer includes multiple products or a lab has restocked an item. The CoA should support purity, identity and contaminant screening as described for the batch; read the exact figures from the batch CoA rather than inferring them from a marketing headline. Published homepage claims such as “≥99% Verified Purity” should be reconfirmed against the live site and the batch document.
If the protocol includes several vials, build the cross-reference sheet in protocol order, then add a second column for storage location. When the original materials were sourced through Uk peptides suppliers, the receiving lab should still verify the live batch CoA at the point of transfer. The supplier’s CoA is a record, not a substitute for the receiving lab’s own documentation check. Lyophilised materials are typically stored at –20°C or below, sealed with desiccant, and protected from moisture, heat and light; confirm the storage condition on the CoA and the product page before placing the vials. Reconstituted material, where an in-vitro assay requires it, should be handled within the laboratory workflow and stored at 2–8°C for short-term laboratory use, not for human or veterinary use.
Record any discrepancy immediately. If the CoA is missing, or if the label reference and CoA do not align, quarantine the vial and do not sign off the transfer. The receiving lab can then contact the supplier with the full label reference and, where available, the ITR. Research Sciences advises quoting the reference when contacting the shop about documentation. That single step makes the query traceable and reduces the risk of a documentation mix-up during a busy transfer.
Handling mismatches, restocks, and the final documentation check
Mismatches are not always signs of a serious error, but they must be resolved before the protocol is accepted. A restocked product may carry the same ITR as earlier stock, while packaging or cap colour may differ. Research Sciences states that restocked products may carry the same ITR and that an ITR links to associated sample testing reports; it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. Avoid treating a shared ITR as proof of batch equivalence. The batch CoA and label reference remain the primary check.
A practical case is a transfer of a BPC-157 10mg vial labelled BPC10-03/27 from a sending lab to a receiving lab. The sending lab includes a CoA file named for the product, but the receiving lab notices that the CoA’s batch identifier does not match the label reference. The receiving lab quarantines the vial, records the discrepancy on the cross-reference sheet, and contacts the supplier with the label reference. Until the supplier confirms the correct CoA, the vial is not entered into the active protocol. The example shows why the label reference must travel with the CoA and why a file name alone is not enough.
If the CoA is correct but the vial is near expiry, the receiving lab should assess whether the transfer timeline still fits the research workflow. Expiry information on the label is part of the reference, so a single character can change the documentation trail. The lab should also check whether the protocol requires a blended peptide; Research Sciences states that it does not supply blended peptides and recommends buying peptides individually and combining only within a controlled experimental design. That matters when a transferred protocol lists a combination product: each individual vial should have its own label reference and CoA.
The final documentation check should be signed by the person accepting the transfer. File the cross-reference sheet, the CoAs, the label reference list and any supplier correspondence together. If the protocol is later audited, the lab should be able to move from a vial to its CoA without guesswork. All materials are research-use-only and are not for human or veterinary use. The receiving lab is responsible for lawful use, safe handling, storage and disposal, including compliance with relevant UK regulations such as COSHH and laboratory safety standards. The aim is a clean, traceable handover the receiving laboratory can defend.
Beirut native turned Reykjavík resident, Elias trained as a pastry chef before getting an MBA. Expect him to hop from crypto-market wrap-ups to recipes for rose-cardamom croissants without missing a beat. His motto: “If knowledge isn’t delicious, add more butter.”